HCPLive

Hyperbaric Oxygen Improves Function Long After Stroke

 
FRIDAY, Jan. 25 (HealthDay News) -- Hyperbaric oxygen therapy (HBOT) significantly improves neurological function and quality of life in people who had a stroke up to three years earlier, according to a study published online Jan. 15 in PLOS One.

Shai Efrati, M.D., from the Assaf Harofeh Medical Center in Zerifin, Israel, and colleagues treated 74 patients who had suffered a stroke six to 36 months earlier with 40 sessions of HBOT over two months (five days a week, 90 minutes, 100 percent oxygen), either immediately or after a two-month period of no treatment.

The researchers found that HBOT significantly improved neurological function and quality of life, while no improvement was observed during the two-month untreated period. Improvements in brain metabolism, as determined by single photon emission computed tomography, correlated with clinical improvement. Brain activity improved in areas that contained live cells but low activity.

"To conclude, in this study we provide, for the first time, convincing results demonstrating that HBOT can induce significant neurological improvement in post-stroke patients," Efrati and colleagues write. "The neurological improvements in a chronic late stage demonstrate that neuroplasticity can be operative and activated by HBOT even long after acute brain insult."
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 

Most Popular

Recommended Reading

A recent review article summarized the socioeconomic consequences of Klinefelter syndrome, which is the most frequent chromosomal aberration in humans and is associated with hypogonadism and neurocognitive deficits.
Results from 2 trials presented at the recent Heart Rhythm Society meeting suggest that 2 alternative ablation technologies work about as well as those that are commonly used on patients with atrial fibrillation.
The US Food and Drug Association (FDA) granted approval for eluxadoline (Viberzi) and rifaximin (Xifaxan), to treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.
Researchers from the University of Michigan say a new model that uses routine laboratory tests and machine-learning methods to better predict hepatitis C progression can be used to guide patients and doctors through important treatment decisions.
$vAR$